GLIMISAVE M1 TAB
Rs 146.53 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
GLIMISAVE M1 TAB
Glimisave M1 Tablet is designed to effectively manage type 2 diabetes mellitus when diet, exercise, and monotherapy do not provide adequate control. This combination medication includes Glimepiride, which stimulates insulin secretion from the pancreas, and Metformin, which reduces glucose production in the liver and enhances insulin sensitivity. The tablet is usually taken once daily with meals to optimize its efficacy and reduce gastrointestinal side effects. Common side effects may include nausea, diarrhea, stomach pain, and loss of appetite. It is essential to follow the prescribed dosage and consult a healthcare provider for personalized advice, especially for individuals with underlying health conditions or during pregnancy. Regular monitoring and adherence to a balanced diet and exercise plan are crucial for effective diabetes management.
Product Highlights and Usage:
Active Ingredients: Contains Glimepiride 1 mg and Metformin 500 mg. Benefits: Manages type 2 diabetes mellitus when diet and exercise alone are insufficient. Usage: Taken orally once daily with meals, as prescribed by a physician. Mechanism: Glimepiride increases insulin secretion from the pancreas, Metformin reduces glucose production in the liver, and enhances insulin sensitivity. Safety: Not suitable for individuals with severe kidney or liver disease, type 1 diabetes, or during pregnancy and breastfeeding; consult a doctor before use.
How it works:
GLIMISAVE M1 TABLET helps manage blood glucose levels. Glimepiride enhances insulin release from the pancreas to reduce blood glucose levels, while Metformin lowers glucose production in the liver, slows glucose absorption from the intestine, and improves the body’s sensitivity to insulin.
Directions for use:
Take GLIMISAVE M1 TABLET as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition. Avoid discontinuing GLIMISAVE M1 TABLET without consulting your doctor first.
Warning & Precaution:
PREGNANCY GLIMISAVE M1 TABLET is not recommended during pregnancy. If you are planning to become pregnant, consult your doctor before starting GLIMISAVE M1 TABLET. BREASTFEEDING GLIMISAVE M1 TABLET should not be used while breastfeeding as it may be transmitted through breast milk. Consult your doctor for advice before taking GLIMISAVE M1 TABLET if you are breastfeeding. DRIVING AND OPERATING MACHINERY Exercise caution when driving or operating machinery. If you experience symptoms of low or high blood sugar, such as dizziness, fatigue, shaking, or visual disturbances, avoid these activities. ALCOHOL It is advisable to avoid alcohol while using GLIMISAVE M1 TABLET, as it may affect blood sugar levels and increase the risk of lactic acidosis. Consult your doctor for personalized advice regarding alcohol consumption. KIDNEY GLIMISAVE M1 TABLET is not recommended for patients with severe kidney disease and should be used with caution in those with kidney issues. Your dosage may need adjustment based on kidney function. Consult your doctor before use. LIVER Avoid using GLIMISAVE M1 TABLET if you have severe liver disease. It should be used with caution in patients with liver conditions, and dosage adjustments may be required based on liver function. Consult your doctor for guidance. ALLERGY Do not use GLIMISAVE M1 TABLET if you are allergic to Glimepiride, Metformin, sulfonylureas (such as glipizide or glibenclamide), or sulfonamides (such as sulfamethoxazole). HEART DISEASE GLIMISAVE M1 TABLET is not suitable for individuals with acute heart issues, recent heart attacks, severe circulatory problems, or breathing difficulties related to heart failure. Consult your doctor before use. PEDIATRIC USE GLIMISAVE M1 TABLET is generally not recommended for children and adolescents under 18 years old. Consult a pediatrician for advice. GERIATRIC USE GLIMISAVE M1 TABLET is not recommended for patients aged 75 years or older and should be used with caution in those aged 65 years or older, particularly if kidney function is impaired. Your doctor may monitor kidney function more frequently. Consult your doctor before use.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$